Find Research Outputs

2019

Antigen-delivery through invariant chain (CD74) boosts CD8 and CD4 T cell immunity

Mensali, N., Grenov, A., Pati, N. B., Dillard, P., Myhre, M. R., Gaudernack, G., Kvalheim, G., Inderberg, E. M., Bakke, O. & Walchli, S., Mar 4 2019, In : OncoImmunology. 8, 3, 1558663.

Research output: Contribution to journalArticle

Immunity
T-Lymphocytes
Antigens
Peptides
Neoplasms

Antigenic site-specific competitive antibody responses to the fusion protein of respiratory syncytial virus were associated with viral clearance in hematopoietic cell transplantation adults

Ye, X., Iwuchukwu, O. P., Avadhanula, V., Aideyan, L. O., McBride, T. J., Ferlic-Stark, L. L., Patel, K. D., Piedra, F. A., Shah, D. J., Chemaly, R. F. & Piedra, P. A., Jan 1 2019, In : Frontiers in immunology. 10, MAR, 706.

Research output: Contribution to journalArticle

Open Access
Respiratory Syncytial Viruses
Cell Transplantation
Antibody Formation
Antibodies
Neutralizing Antibodies

Antileukemia effects of Notch-mediated inhibition of oncogenic PLK1 in B-cell acute lymphoblastic leukemia

Kannan, S., Aitken, M. J. L., Herbrich, S. M., Golfman, L. S., Hall, M. G., Mak, D. H., Burks, J. K., Song, G., Konopleva, M., Mullighan, C. G., Chandra, J. & Zweidler-McKay, P. A., Jan 1 2019, In : Molecular cancer therapeutics. 18, 9, p. 1615-1627 13 p.

Research output: Contribution to journalArticle

Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Lymphocytes
Heterografts
Cell Death
B-Lymphocyte Subsets

Antinociceptive effectiveness of the inhibition of NCX reverse-mode action in rodent neuropathic pain model

Huang, Y., Wen, L. L., Xie, J. D., Ouyang, H. D., Chen, D. T. & Zeng, W-A., Aug 8 2019, In : Molecular pain. 15

Research output: Contribution to journalArticle

Open Access
Spinal Ganglia
Neuralgia
Spinal Nerves
Rodentia
Spinal Injections

Anti-PD-1 monoclonal antibody MEDI0680 in a phase i study of patients with advanced solid malignancies

Naing, A., Infante, J., Goel, S., Burris, H., Black, C., Marshall, S., Achour, I., Barbee, S., May, R., Morehouse, C., Pollizzi, K., Song, X., Steele, K., Elgeioushi, N., Walcott, F., Karakunnel, J., Lorusso, P., Weise, A., Eder, J., Curti, B. & 1 others, Oberst, M., Aug 22 2019, In : Journal for immunotherapy of cancer. 7, 1, 225.

Research output: Contribution to journalArticle

Open Access
Kidney Neoplasms
Melanoma
Pharmacokinetics
Monoclonal Antibodies
T-Lymphocytes
1 Citation (Scopus)

Antipsychotics for patients with pain

Shin, S. W., Lee, J. S., Abdi, S., Lee, S. J. & Kim, K. H., Jan 1 2019, In : Korean Journal of Pain. 32, 1, p. 3-11 9 p.

Research output: Contribution to journalArticle

Antipsychotic Agents
Pain
Antidepressive Agents
Serotonin
Psychotic Affective Disorders
3 Citations (Scopus)
Antilymphocyte Serum
Stem Cell Transplantation
Graft vs Host Disease
Acute Myeloid Leukemia
Leukemia
1 Citation (Scopus)

Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer

Lee, J., Lim, B., Pearson, T., Choi, K., Fuson, J. A., Bartholomeusz, C., Paradiso, L. J., Myers, T., Tripathy, D. & Ueno, N. T., Jan 1 2019, In : Breast Cancer Research and Treatment.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Neoplasm Metastasis
Neoplasms
Heterografts
Staining and Labeling

Antitumor effects of anlotinib in thyroid cancer

Ruan, X., Shi, X., Dong, Q., Yu, Y., Hou, X., Song, X., Wei, X., Chen, L. & Gao, M., Jan 1 2019, In : Endocrine-Related Cancer. 26, 1, p. 153-164 12 p.

Research output: Contribution to journalArticle

Thyroid Neoplasms
Clinical Trials, Phase I
Heterografts
Cell Survival
Thyroid Gland
2 Citations (Scopus)

Anti-tumor immunity induced by ectopic expression of viral antigens is transient and limited by immune escape

Dharmaraj, N., Piotrowski, S. L., Huang, C., Newton, J. M., Golfman, L. S., Hanoteau, A., Koshy, S. T., Li, A. W., Pulikkathara, M. X., Zhang, B., Burks, J. K., Mooney, D. J., Lei, Y. L., Sikora, A. G. & Young, S., Apr 3 2019, In : OncoImmunology. 8, 4, e1568809.

Research output: Contribution to journalArticle

Viral Antigens
Immunity
Neoplasms
Cancer Vaccines
Human papillomavirus 16

Anti-α4β7 integrin monoclonal antibody (vedolizumab) for the treatment of steroid-resistant severe intestinal acute graft-versus-host disease

Danylesko, I., Bukauskas, A., Paulson, M., Peceliunas, V., Gedde-Dahl d.y, T., Shimoni, A., Shouval, R., Griskevicius, L., Floisand, Y. & Nagler, A., Jul 1 2019, In : Bone marrow transplantation. 54, 7, p. 987-993 7 p.

Research output: Contribution to journalArticle

Graft vs Host Disease
Integrins
Steroids
Monoclonal Antibodies
Therapeutics

Anti-αFR CAR-engineered NK-92 Cells Display Potent Cytotoxicity Against αfR-positive Ovarian Cancer

Ao, X., Yang, Y., Li, W., Tan, Y., Guo, W., Ao, L., He, X., Wu, X., Xia, X. J-C., Xu, X. & Guo, J., Jan 1 2019, In : Journal of Immunotherapy.

Research output: Contribution to journalArticle

Folate Receptor 1
Antigen Receptors
Natural Killer Cells
Ovarian Neoplasms
Neoplasms
2 Citations (Scopus)

Antrodia camphorata inhibits epithelial-to-mesenchymal transition by targeting multiple pathways in triple-negative breast cancers

Hseu, Y. C., Chang, G. R., Pan, J. Y., Rajendran, P., Mathew, D. C., Li, M. L., Liao, J. W., Chen, T-L. & Yang, H. L., Apr 1 2019, In : Journal of Cellular Physiology. 234, 4, p. 4125-4139 15 p.

Research output: Contribution to journalArticle

Antrodia
Triple Negative Breast Neoplasms
Epithelial-Mesenchymal Transition
Cadherins
Cells
1 Citation (Scopus)

Antrodia cinnamomea, a treasured medicinal mushroom, induces growth arrest in breast cancer cells, T47D cells: New mechanisms emerge

Chen, Y. C., Liu, Y. C., El-Shazly, M., Wu, T. Y., Chang, J. G. & Wu, Y-C., Feb 2 2019, In : International journal of molecular sciences. 20, 4, 833.

Research output: Contribution to journalArticle

Open Access
Antrodia
Agaricales
breast
Ethanol
ethyl alcohol
Hemangiosarcoma
Bone Marrow
Neoplasms
1 Citation (Scopus)

An update for LI-RADS: Version 2018. Why so soon after version 2017?

Kielar, A. Z., Chernyak, V., Bashir, M. R., Do, R. K., Fowler, K. J., Santillan, C., Sirlin, C. B., Mitchell, D. G., Cerny, M., Tang, A., Elsayes, K. M., Kamaya, A., Kono, Y. & Arora, S. S., Jan 1 2019, In : Journal of Magnetic Resonance Imaging.

Research output: Contribution to journalLetter

An update in the management of pediatric sarcoma

Sandler, G., Yokoi, A. & Hayes-Jordan, A., Jun 1 2019, In : Current opinion in pediatrics. 31, 3, p. 368-377 10 p.

Research output: Contribution to journalArticle

Sarcoma
Pediatrics
Therapeutics
Genetic Predisposition to Disease
Neoplasms
1 Citation (Scopus)

An Update of the Appropriate Treatment Strategies in Anaplastic Thyroid Cancer: A Population-Based Study of 735 Patients

Huang, N. S., Shi, X., Lei, B. W., Wei, W. J., Lu, Z. W., Yu, P. C., Wang, Y., Ji, Q. & Wang, Y. L., Jan 1 2019, In : International Journal of Endocrinology. 2019, 8428547.

Research output: Contribution to journalArticle

Open Access
Thyroidectomy
Population
Drug Therapy
Therapeutics
Neoplasm Metastasis
3 Citations (Scopus)

An update on the management and outcomes of cancer patients with severe aortic stenosis

Schechter, M., Balanescu, D. V., Donisan, T., Dayah, T. J., Kar, B., Gregoric, I., Giza, D. E., Song, J., Lopez-Mattei, J., Kim, P., Balanescu, S. M., Cilingiroglu, M., Toutouzas, K., Smalling, R. W., Marmagkiolis, K. & Iliescu, C., Sep 1 2019, In : Catheterization and Cardiovascular Interventions. 94, 3, p. 438-445 8 p.

Research output: Contribution to journalArticle

Aortic Valve Stenosis
Neoplasms
Aortic Valve
Survival
Therapeutics

AP-1 transcription factors as regulators of immune responses in cancer

Atsaves, V., Leventaki, V., Rassidakis, G. Z. & Claret, F-X., Jul 1 2019, In : Cancers. 11, 7, 1037.

Research output: Contribution to journalReview article

Open Access
Transcription Factor AP-1
Transcription Factors
Neoplasms
Mitogen-Activated Protein Kinases
Immunotherapy
14 Citations (Scopus)

Apalutamide for metastatic, castration-sensitive prostate cancer

Chi, K. N., Agarwal, N., Bjartell, A., Chung, B. H., Gomes, A. J. P. D. S., Given, R., Soto, A. J., Merseburger, A. S., Ozguroglu, M., Uemura, H., Ye, D., Deprince, K., Naini, V., Li, J., Cheng, S., Yu, M. K., Zhang, K., Larsen, J. S., Mccarthy, S. & Chowdhury, S., Jul 4 2019, In : New England Journal of Medicine. 381, 1, p. 13-24 12 p.

Research output: Contribution to journalArticle

Castration
Prostatic Neoplasms
Androgens
Placebos
docetaxel

A pan-cancer analysis of synonymous mutations

Sharma, Y., Miladi, M., Dukare, S., Boulay, K., Caudron-Herger, M., Groß, M., Backofen, R. & Diederichs, S., Dec 1 2019, In : Nature communications. 10, 1, 2569.

Research output: Contribution to journalArticle

Open Access
mutations
cancer
Messenger RNA
RNA
Protein folding

A panel of three plasma microRNAs for colorectal cancer diagnosis

Tan, Y., Lin, J. J., Yang, X. F., Gou, D. M., Fu, L-W., Li, F. R. & Yu, X. F., Jun 1 2019, In : Cancer Epidemiology. 60, p. 67-76 10 p.

Research output: Contribution to journalArticle

MicroRNAs
Colorectal Neoplasms
Poly T
Calcium Signaling
Polyps

A Pathologic Complete Response to Neoadjuvant Chemotherapy and Immunotherapy Followed by Surgery in a Patient With NSCLC

Ma, X., Li, B., Li, Y., Lu, L. & Chen, H., May 1 2019, In : Journal of Thoracic Oncology. 14, 5, p. e104-e106

Research output: Contribution to journalLetter

Immunotherapy
Drug Therapy
2 Citations (Scopus)

APC-activated long noncoding RNA inhibits colorectal carcinoma pathogenesis through reduction of exosome production

Wang, F. W., Cao, C. H., Han, K., Zhao, Y. X., Cai, M. Y., Xiang, Z. C., Zhang, J. X., Chen, J. W., Zhong, L. P., Huang, Y., Zhou, S. F., Jin, X. H., Guan, X-Y., Xu, R-H. & Xie, D., Feb 1 2019, In : Journal of Clinical Investigation. 129, 2, p. 727-743 17 p.

Research output: Contribution to journalArticle

Long Noncoding RNA
Exosomes
Adenomatous Polyposis Coli
Colorectal Neoplasms
APC Genes

APC ameliorates pulmonary complications in cGVHD

Afshar-Kharghan, V., Aug 29 2019, In : Blood. 134, 9, p. 724-725 2 p.

Research output: Contribution to journalComment/debate

Open Access
Lung

A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma

Zhang, Y., Xu, J., Hua, J., Liu, J., Liang, C., Meng, Q., Wei, M., Zhang, B., Yu, X. & Shi, S., Aug 29 2019, In : Journal for immunotherapy of cancer. 7, 1, 233.

Research output: Contribution to journalArticle

Open Access
Adenocarcinoma
Biomarkers
Ligands
Survival
Transforming Growth Factors
3 Citations (Scopus)

A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma

Milgrom, S. A., Elhalawani, H., Lee, J., Wang, Q., Mohamed, A. S. R., Dabaja, B. S., Pinnix, C. C., Gunther, J., Court, L. E., Uppore Kukkillaya, A. R., Fuller, C., Akhtari, M., Aristophanous, M., Mawlawi, O., Chuang, H. H., Sulman, E. P., Lee, H. J., Hagemeister, F. B., Oki, Y., Fanale, M. A. & 1 others, Smith, G. L., Dec 1 2019, In : Scientific reports. 9, 1, 1322.

Research output: Contribution to journalArticle

Open Access
Hodgkin Disease
Glycolysis
Tumor Burden
Mediastinal Diseases
Area Under Curve
5 Citations (Scopus)

A Phase 1/2 Trial of Reirradiation for Diffuse Intrinsic Pontine Glioma

Amsbaugh, M. J., Mahajan, A., Thall, P. F., McAleer, M. F., Paulino, A. D. C., Grosshans, D. R., Khatua, S., Ketonen, L., Fontanilla, H. & McGovern, S. L., May 1 2019, In : International Journal of Radiation Oncology Biology Physics. 104, 1, p. 144-148 5 p.

Research output: Contribution to journalArticle

Glioma
dosage
toxicity
progressions
Disease-Free Survival
1 Citation (Scopus)

A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas

Jones, R. L., Chawla, S. P., Attia, S., Schöffski, P., Gelderblom, H., Chmielowski, B., Le Cesne, A., Van Tine, B. A., Trent, J. C., Patel, S., Wagner, A. J., Chugh, R., Heyburn, J. W., Weil, S. C., Wang, W., Viele, K. & Maki, R. G., Jul 15 2019, In : Cancer. 125, 14, p. 2445-2454 10 p.

Research output: Contribution to journalArticle

Open Access
docetaxel
gemcitabine
Sarcoma
Confidence Intervals
Safety

A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors

Hong, D. S., Rasco, D., Veeder, M., Luke, J. J., Chandler, J., Balmanoukian, A., George, T. J., Munster, P., Berlin, J. D., Gutierrez, M., Mita, A., Wakelee, H., Samakoglu, S., Guan, S., Dimery, I., Graef, T. & Borazanci, E., Jul 1 2019, In : Oncology (Switzerland). 97, 2, p. 102-111 10 p.

Research output: Contribution to journalArticle

Open Access
Ligands
Breast Neoplasms
Non-Small Cell Lung Carcinoma
Neoplasms
Pancreatic Neoplasms

A Phase 1 Pilot Study of Preoperative Radiation Therapy for Prostate Cancer: Long-Term Toxicity and Oncologic Outcomes

Glicksman, R., Sanmamed, N., Thoms, J., Zlotta, A. R., Finelli, A., van der Kwast, T., Sweet, J., Jewett, M., Klotz, L. H., Rosewall, T., Fleshner, N. E., Bristow, R. G., Warde, P. & Berlin, A., May 1 2019, In : International Journal of Radiation Oncology Biology Physics. 104, 1, p. 61-66 6 p.

Research output: Contribution to journalArticle

toxicity
radiation therapy
Prostatic Neoplasms
Radiotherapy
cancer

A phase 2 study of brentuximab vedotin in patients with CD30-positive advanced systemic mastocytosis

Gotlib, J., Baird, J. H., George, T. I., Langford, C., Reyes, I., Abuel, J., Perkins, C., Schroeder, K., Bose, P. & Verstovsek, S., Jan 1 2019, In : Blood Advances. 3, 15, p. 2264-2271 8 p.

Research output: Contribution to journalArticle

Open Access
Systemic Mastocytosis
Mast Cells
Mastocytosis
Tryptases
Bone Marrow Cells
1 Citation (Scopus)

A phase 2 study of pracinostat combined with ruxolitinib in patients with myelofibrosis

Bose, P., Swaminathan, M., Pemmaraju, N., Ferrajoli, A., Jabbour, E. J., Daver, N., DiNardo, C., Alvarado, Y., Yilmaz, M., Huynh-Lu, J., Qiao, W., Wang, X., Matamoros Jr, A., Zhou, L., Pierce, S., Schroeder, K. D., Kantarjian, H. M. & Verstovsek, S., Jun 7 2019, In : Leukemia and Lymphoma. 60, 7, p. 1767-1774 8 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Histone Deacetylase Inhibitors
Palpation
Splenomegaly
INCB018424
2 Citations (Scopus)

A phase I, open-label, multicenter, dose-escalation study of the oral selective FGFR inhibitor debio 1347 in patients with advanced solid tumors harboring FGFR gene alterations

Voss, M. H., Hierro, C., Heist, R. S., Cleary, J. M., Meric-Bernstam, F., Tabernero, J., Janku, F., Gandhi, L., John Iafrate, A., Borger, D. R., Ishii, N., Hu, Y., Kirpicheva, Y., Nicolas-Metral, V., Pokorska-Bocci, A., Chessex, A. V., Zanna, C., Flaherty, K. T. & Baselga, J., Jan 1 2019, In : Clinical Cancer Research. 25, 9, p. 2699-2707 9 p.

Research output: Contribution to journalArticle

Open Access
Genes
Neoplasms
Hyperphosphatemia
Pharmacokinetics
Hyperamylasemia
6 Citations (Scopus)

A phase I/IB trial of the vegfr-sparing multikinase ret inhibitor RXDX-105

Drilon, A., Fu, S., Patel, M. R., Fakih, M., Wang, D., Olszanski, A. J., Morgensztern, D., Liu, S. V., Cho, B. C., Bazhenova, L., Rodriguez, C. P., Doebele, R. C., Wozniak, A., Reckamp, K. L., Seery, T., Nikolinakos, P., Hu, Z., Oliver, J. W., Trone, D., McArthur, K. & 3 others, Patel, R., Multani, P. S. & Ahn, M. J., Mar 1 2019, In : Cancer discovery. 9, 3, p. 384-395 12 p.

Research output: Contribution to journalArticle

Open Access
Exanthema
Non-Small Cell Lung Carcinoma
Hypophosphatemia
Neoplasms
Gene Fusion

A Phase I/II Open-Label Study of Nivolumab in Previously Treated Advanced or Recurrent Nasopharyngeal Carcinoma and Other Solid Tumors

Ma, Y., Fang, W., Zhang, Y., Yang, Y., Hong, S., Zhao, Y., Tendolkar, A., Chen, L., Xu, D., Sheng, J., Zhao, H. & Zhang, L., Jul 1 2019, In : Oncologist. 24, 7, p. 891-e431

Research output: Contribution to journalArticle

Open Access
Neoplasms
Pharmacokinetics
Safety
Population
nivolumab
Epidermal Growth Factor
Breast Neoplasms
Neutropenia
Thrombocytopenia
Therapeutics

A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151)

Si, L., Zhang, X-S., Shu, Y., Pan, H., Wu, D., Liu, J., Lou, F., Mao, L., Wang, X., Wen, X., Gu, Y., Zhu, L., Lan, S., Cai, X., Diede, S. J., Zhou, Y., Ge, J., Li, J., Wu, H. & Guo, J., Jun 1 2019, In : Translational Oncology. 12, 6, p. 828-835 8 p.

Research output: Contribution to journalArticle

Open Access
Melanoma
Disease-Free Survival
Therapeutics
Extremities
Safety
4 Citations (Scopus)

A phase I dose-escalation study of veliparib combined with carboplatin and etoposide in patients with extensive-stage small cell lung cancer and other solid tumors

Atrafi, F., Groen, H. J. M., Byers, L. A., Garralda, E., Lolkema, M. P., Sangha, R. S., Viteri, S., Chae, Y. K., Ross Camidge, D., Gabrail, N. Y., Hu, B., Tian, T., Nuthalapati, S., Hoening, E., He, L., Komarnitsky, P. & Calles, A., Jan 15 2019, In : Clinical Cancer Research. 25, 2, p. 496-505 10 p.

Research output: Contribution to journalArticle

Carboplatin
Small Cell Lung Carcinoma
Etoposide
Neoplasms
Disease Progression

A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer

Bang, Y. J., Kang, Y. K., Ng, M., Chung, H. C., Wainberg, Z. A., Gendreau, S., Chan, W. Y., Xu, N., Maslyar, D., Meng, R., Chau, I. & Ajani, J. A., Feb 1 2019, In : European Journal of Cancer. 108, p. 17-24 8 p.

Research output: Contribution to journalArticle

Esophagogastric Junction
Stomach
Disease-Free Survival
Placebos
Neoplasms

A phase II study of addition of pracinostat to a hypomethylating agent in patients with myelodysplastic syndromes who have not responded to previous hypomethylating agent therapy

Yalniz, F. F., Berdeja, J. G., Maris, M. B., Lyons, R. M., Reeves, J. A., Essell, J. H., Patel, P., Sekeres, M., Hughes, A., Mappa, S. & Garcia-Manero, G., Jan 1 2019, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Proxy
Therapeutics
Bone Marrow
Histone Deacetylase Inhibitors
oxaliplatin
Anal Canal
Squamous Cell Carcinoma
Radiotherapy
Colostomy

A phase II study of carfilzomib in the treatment of relapsed/refractory mantle cell lymphoma

Lee, H. J., Badillo, M., Romaguera, J. & Wang, L., Feb 1 2019, In : British Journal of Haematology. 184, 3, p. 460-462 3 p.

Research output: Contribution to journalLetter

Mantle-Cell Lymphoma
carfilzomib
1 Citation (Scopus)

A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology Group

Isakoff, M. S., Goldsby, R., Villaluna, D., Krailo, M. D., Hingorani, P., Collier, A., Morris, C. D., Kolb, E. A., Doski, J. J., Womer, R. B., Gorlick, R. & Janeway, K. A., Feb 1 2019, In : Pediatric Blood and Cancer. 66, 2, e27524.

Research output: Contribution to journalArticle

eribulin
Osteosarcoma
Leukemia, Myelomonocytic, Chronic
Myelodysplastic Syndromes
Diploidy
Cytogenetics
Survival
1 Citation (Scopus)

A phase II trial of eltrombopag for patients with chronic lymphocytic leukaemia (CLL) and thrombocytopenia

Paul, S., Jain, N., Ferrajoli, A., O'Brien, S., Burger, J. A., Keating, M. & Wierda, W. G., May 1 2019, In : British Journal of Haematology. 185, 3, p. 606-608 3 p.

Research output: Contribution to journalLetter

Thrombopoietin
B-Cell Chronic Lymphocytic Leukemia
Thrombocytopenia
eltrombopag

A phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapy

Ornstein, M. C., Wood, L. S., Hobbs, B. P., Allman, K. D., Martin, A., Bevan, M., Gilligan, T. D., Garcia, J. A. & Rini, B. I., May 16 2019, In : Journal for immunotherapy of cancer. 7, 1, 127.

Research output: Contribution to journalArticle

Open Access
Renal Cell Carcinoma
Tumor Burden
Therapeutics
nivolumab
Phase II Clinical Trials

A Phase II Trial of Ziv-Aflibercept in Patients with Advanced Pancreatic Neuroendocrine Tumors

Halperin, D. M., Lee, J. J., Ng, C. S., Strosberg, J. R., Estrella, J. S., Dagohoy, C. G., Dasari, N. V. & Yao, J. C., Mar 1 2019, In : Pancreas. 48, 3, p. 381-386 6 p.

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Perfusion
Tomography
Vascular Endothelial Growth Factor A
Immunoglobulin Fc Fragments

A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia

Döhner, H., Müller-Tidow, C., Lübbert, M., Fiedler, W., Kraemer, A., Westermann, J., Bug, G., Schlenk, R. F., Krug, U., Goeldner, R. G., Hilbert, J., Taube, T. & Ottmann, O. G., May 1 2019, In : British Journal of Haematology. 185, 3, p. 583-587 5 p.

Research output: Contribution to journalLetter

Aurora Kinase B
Cytarabine
Acute Myeloid Leukemia